Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study.

Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet (2007) 3.62

Exposure to traffic pollution and increased risk of rheumatoid arthritis. Environ Health Perspect (2009) 1.70

Occupational exposure to textile dust increases the risk of rheumatoid arthritis: results from a Malaysian population-based case-control study. Ann Rheum Dis (2015) 1.44

Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun (2012) 1.43

Geographic variation in rheumatoid arthritis incidence among women in the United States. Arch Intern Med (2008) 1.34

Environmental and gene-environment interactions and risk of rheumatoid arthritis. Rheum Dis Clin North Am (2012) 1.26

When and where does inflammation begin in rheumatoid arthritis? Curr Opin Rheumatol (2014) 1.08

Ambient air pollution exposures and risk of rheumatoid arthritis: results from the Swedish EIRA case-control study. Ann Rheum Dis (2012) 1.06

Citrullination of proteins: a common post-translational modification pathway induced by different nanoparticles in vitro and in vivo. Nanomedicine (Lond) (2012) 1.00

Association of environmental and genetic factors and gene-environment interactions with risk of developing rheumatoid arthritis. Arthritis Care Res (Hoboken) (2013) 0.96

Ambient air pollution exposures and risk of rheumatoid arthritis. Arthritis Care Res (Hoboken) (2013) 0.94

Genetics, environment, and gene-environment interactions in the development of systemic rheumatic diseases. Rheum Dis Clin North Am (2014) 0.93

Using lifestyle factors to identify individuals at higher risk of inflammatory polyarthritis (results from the European Prospective Investigation of Cancer-Norfolk and the Norfolk Arthritis Register--the EPIC-2-NOAR Study). Ann Rheum Dis (2013) 0.92

The multifaceted aspects of interstitial lung disease in rheumatoid arthritis. Biomed Res Int (2013) 0.91

Autoantibodies to posttranslational modifications in rheumatoid arthritis. Mediators Inflamm (2014) 0.86

Sex-specific environmental influences on the development of autoimmune diseases. Clin Immunol (2013) 0.86

Silicon, a Possible Link between Environmental Exposure and Autoimmune Diseases: The Case of Rheumatoid Arthritis. Arthritis (2012) 0.85

Interaction analysis between HLA-DRB1 shared epitope alleles and MHC class II transactivator CIITA gene with regard to risk of rheumatoid arthritis. PLoS One (2012) 0.84

Specific association of type 1 diabetes mellitus with anti-cyclic citrullinated peptide-positive rheumatoid arthritis. Arthritis Rheum (2009) 0.83

Relationship between air pollution and positivity of RA-related autoantibodies in individuals without established RA: a report on SERA. Ann Rheum Dis (2013) 0.83

Associations of Smoking and Age With Inflammatory Joint Signs Among Unaffected First-Degree Relatives of Rheumatoid Arthritis Patients: Results From Studies of the Etiology of Rheumatoid Arthritis. Arthritis Rheumatol (2016) 0.83

Genetics of Interstitial Lung Disease: Vol de Nuit (Night Flight). Clin Med Insights Circ Respir Pulm Med (2015) 0.81

Calcium and vitamin D supplementation and incident rheumatoid arthritis: the Women's Health Initiative Calcium plus Vitamin D trial. Rheumatol Int (2011) 0.80

Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features. Respir Med (2016) 0.79

Association between Air Pollution and the Development of Rheumatic Disease: A Systematic Review. Int J Rheumatol (2016) 0.78

Defining populations at risk of rheumatoid arthritis: the first steps to prevention. Nat Rev Rheumatol (2014) 0.78

The Roles of Cigarette Smoking and the Lung in the Transitions Between Phases of Preclinical Rheumatoid Arthritis. Curr Rheumatol Rep (2016) 0.76

Epidemiology research in rheumatology-progress and pitfalls. Nat Rev Rheumatol (2015) 0.75

The Mechanisms Underlying Chronic Inflammation in Rheumatoid Arthritis from the Perspective of the Epigenetic Landscape. J Immunol Res (2016) 0.75

Two Cases of Tsunami Dust Pneumonia: Organizing Pneumonia Caused by the Inhalation of Dried Tsunami Sludge after the 2011 Great East Japan Earthquake. Intern Med (2016) 0.75

Physical workload is associated with increased risk of rheumatoid arthritis: results from a Swedish population-based case-control study. RMD Open (2017) 0.75

Usage of skin care products and risk of rheumatoid arthritis: results from the Swedish EIRA study. Arthritis Res Ther (2012) 0.75

Patterns of background factors related to early RA patients' conceptions of the cause of their disease. Clin Rheumatol (2010) 0.75

Is Male Rheumatoid Arthritis an Occupational Disease? A Review. Open Rheumatol J (2017) 0.75

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05

Estimability and estimation in case-referent studies. Am J Epidemiol (1976) 22.43

Confidence interval estimation of interaction. Epidemiology (1992) 6.85

Concepts of interaction. Am J Epidemiol (1980) 4.80

Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis (2003) 4.36

Smoking and risk of rheumatoid arthritis. J Rheumatol (1993) 3.63

Macrophages in rheumatoid arthritis. Arthritis Res (2000) 3.40

TAK1 is critical for IkappaB kinase-mediated activation of the NF-kappaB pathway. J Mol Biol (2003) 3.17

Oral contraceptives, cigarette smoking and other factors in relation to arthritis. Contraception (1987) 2.21

Early inflammatory polyarthritis: results from the norfolk arthritis register with a review of the literature. I. Risk factors for the development of inflammatory polyarthritis and rheumatoid arthritis. Rheumatology (Oxford) (2000) 2.01

Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect (1999) 1.95

The role of NF-kappaB in the regulation of cell stress responses. Int Immunopharmacol (2002) 1.79

Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis. Blood (2002) 1.57

Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology (Oxford) (2003) 1.32

Silica exposure and rheumatoid arthritis: a follow up study of granite workers 1940-81. Br Med J (Clin Res Ed) (1987) 1.27

Kidney disease and arthritis in a cohort study of workers exposed to silica. Epidemiology (2001) 1.23

Connective tissue disease and silicosis. Am J Ind Med (1999) 1.11

Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis. Arthritis Res (2000) 1.08

On the organization of an early arthritis clinic. Best Pract Res Clin Rheumatol (2001) 1.08

Matrix metalloproteinases 2, 9, and 13, and tissue inhibitors of metalloproteinases 1 and 2 in experimental lung silicosis. Am J Respir Crit Care Med (1999) 1.07

Rheumatoid arthritis in workers exposed to silica in the pottery industry. Occup Environ Med (2000) 1.02

Serum levels of soluble Fas ligand in patients with silicosis. Clin Exp Immunol (1999) 1.01

Relationship between silicosis and rheumatoid arthritis. Thorax (1986) 0.97

Determinants of dust exposure in tunnel construction work. Appl Occup Environ Hyg (2002) 0.94

Regulation of the activation of nuclear factor kappaB by mitochondrial respiratory function: evidence for the reactive oxygen species-dependent and -independent pathways. Antioxid Redox Signal (2002) 0.93

Exposure to silica dust in the Danish stone industry. Scand J Work Environ Health (1989) 0.93

Treating human autoimmune disease by depleting B cells. Ann Rheum Dis (2002) 0.93

Essential role of NF-kappa B activation in silica-induced inflammatory mediator production in macrophages. Biochem Biophys Res Commun (1995) 0.92

Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases, and extracellular matrix mRNA following exposure to mineral fibers and cigarette smoke in vivo. Environ Health Perspect (1997) 0.88

Decreased catecholamine-induced cell death in B lymphocytes from patients with rheumatoid arthritis. Ann N Y Acad Sci (2002) 0.85

Rat alveolar and interstitial macrophages in the fibrosing stage following quartz exposure. Hum Exp Toxicol (2000) 0.80

Promoter identification of CIKS, a novel NF-kappaB activating gene, and regulation of its expression. Gene (2003) 0.78

EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 4.83

Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59

Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis (2003) 4.36

Type of occupation and near-future hospitalization for myocardial infarction and some other diagnoses. Int J Epidemiol (1985) 3.82

Epidermal Langerhans cells express Ia antigens. Nature (1977) 3.51

Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor alpha blockers can make sense. Ann Rheum Dis (2003) 3.43

Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study. Ann Rheum Dis (2008) 3.42

Job strain in relation to body mass index: pooled analysis of 160 000 adults from 13 cohort studies. J Intern Med (2011) 3.14

Unemployment and mortality--a longitudinal prospective study on selection and causation in 49321 Swedish middle-aged men. J Epidemiol Community Health (2010) 3.13

Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J Immunol Methods (1988) 2.84

Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis (2001) 2.69

Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis. Arthritis Rheum (2007) 2.66

Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis (2005) 2.62

Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. Arthritis Rheum (1986) 2.56

Myocardial infarction risk and psychosocial work environment: an analysis of the male Swedish working force. Soc Sci Med (1982) 2.56

Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study. BMJ (1998) 2.51

Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists. Ann Rheum Dis (2005) 2.46

Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis (2005) 2.43

Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health (1994) 2.41

Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006. J Intern Med (2010) 2.30

Sex differences in survival after myocardial infarction in Sweden; data from the Swedish National Acute Myocardial Infarction Register. Eur Heart J (2001) 2.30

Sleep disturbances, work stress and work hours: a cross-sectional study. J Psychosom Res (2002) 2.29

Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis. Arthritis Rheumatol (2014) 2.28

Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis (2008) 2.27

An international two-stage genome-wide search for schizophrenia susceptibility genes. Nat Genet (1995) 2.26

Citrullination is an inflammation-dependent process. Ann Rheum Dis (2006) 2.25

Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial. Arthritis Rheum (2008) 2.17

A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden. Int J Epidemiol (2001) 2.11

High effort, low reward, and cardiovascular risk factors in employed Swedish men and women: baseline results from the WOLF Study. J Epidemiol Community Health (1998) 2.10

Consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 2.07

Appearance of anti-HLA-DR-reactive cells in normal and rheumatoid synovial tissue. Scand J Immunol (1981) 2.02

Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci U S A (1982) 1.99

T lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones. Scand J Immunol (1985) 1.96

Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis (2005) 1.96

Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) (2001) 1.96

Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum (1989) 1.95

Swedish registers to examine drug safety and clinical issues in RA. Ann Rheum Dis (2006) 1.93

Hormonal regulation of the expression of Ia antigens on mammary gland epithelium. Eur J Immunol (1980) 1.90

Homologous type II collagen induces chronic and progressive arthritis in mice. Arthritis Rheum (1986) 1.90

Incidence of arthritis and autoreactivity of anti-collagen antibodies after immunization of DBA/1 mice with heterologous and autologous collagen II. Clin Exp Immunol (1985) 1.89

Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results. Ann Rheum Dis (2005) 1.85

Phenotypic characterization of synovial tissue cells in situ in different types of synovitis. Arthritis Rheum (1983) 1.78

Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005. Ann Rheum Dis (2005) 1.77

Occurrence of Ia antigens on tissues on non-lymphoid origin. Nature (1978) 1.76

Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol (2001) 1.72

Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles. Ann Rheum Dis (2008) 1.71

Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis (1995) 1.71

In situ identification of T lymphocyte subsets and HLA-DR expressing cells in the human skin tuberculin reaction. Clin Exp Immunol (1982) 1.71

Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register. Ann Rheum Dis (2008) 1.69

Mental fatigue, work and sleep. J Psychosom Res (2004) 1.69

Occupation and osteoarthrosis of the hip and knee: a register-based cohort study. Int J Epidemiol (1991) 1.67

A vegan diet free of gluten improves the signs and symptoms of rheumatoid arthritis: the effects on arthritis correlate with a reduction in antibodies to food antigens. Rheumatology (Oxford) (2001) 1.66

Small-area variations in sales of TNF inhibitors in Sweden between 2000 and 2009. Scand J Rheumatol (2010) 1.65

Immunological changes in human skeletal muscle and blood after eccentric exercise and multiple biopsies. J Physiol (2000) 1.63

Evolutionary relationship between immunoglobulins and transplantation antigens. Proc Natl Acad Sci U S A (1975) 1.62

Attack rate, mortality and case fatality for acute myocardial infarction in Sweden during 1987-95. Results from the national AMI register in Sweden. J Intern Med (2000) 1.61

Role of T lymphocytes in collagen II induced arthritis in rats. Clin Exp Immunol (1983) 1.58

Adjuvant oils induce arthritis in the DA rat. I. Characterization of the disease and evidence for an immunological involvement. J Autoimmun (1991) 1.57

Dose escalation of infliximab in clinical practice: improvements seen may be explained by a regression-like effect. Ann Rheum Dis (2004) 1.56

The role of adherent HLA-DR+ mononuclear cells in autologous and allogeneic MLR. J Immunol (1981) 1.53

Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment. Ann Rheum Dis (2000) 1.53

Alcohol consumption is associated with decreased risk of rheumatoid arthritis: results from two Scandinavian case-control studies. Ann Rheum Dis (2008) 1.49

Job, psychological factors and coronary heart disease. Swedish prospective findings and US prevalence findings using a new occupational inference method. Adv Cardiol (1982) 1.49

High antibody response to autologous type II collagen is restricted to H-2q. Immunogenetics (1986) 1.49

Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis. Arthritis Rheum (2000) 1.49

Relationship between HLA-DR-expressing cells and T lymphocytes of different subsets in rheumatoid synovial tissue. Scand J Immunol (1981) 1.48

Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis. Ann Rheum Dis (2003) 1.48

Job characteristics of occupations and myocardial infarction risk:effect of possible confounding factors. Soc Sci Med (1983) 1.47

Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: possible implications for development of vascular proliferative lesions. Lancet (1988) 1.46

The effect of female sex hormones on cancer survival. A register-based study in patients younger than 20 years at diagnosis. JAMA (1990) 1.45

Externally assessed psychosocial work characteristics and diagnoses of anxiety and depression. Occup Environ Med (2008) 1.45

Snus (Swedish smokeless tobacco) use and risk of stroke: pooled analyses of incidence and survival. J Intern Med (2014) 1.45

Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum (1997) 1.45

Treatment with gamma-interferon triggers the onset of collagen arthritis in mice. Arthritis Rheum (1988) 1.44

Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Evidence for an HLA-DR4-restricted IgG response. Arthritis Rheum (1994) 1.44

Chronic bronchitis and risk of coronary heart disease. Lancet (1996) 1.44

Regional variation in the incidence of abdominal aortic aneurysm in Sweden. Br J Surg (2012) 1.43

Aluminosis and dementia. Lancet (1994) 1.43

Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis. Rheumatology (Oxford) (2002) 1.41

Collaboration between developing and developed countries and between developing countries in occupational health research and surveillance. Scand J Work Environ Health (1999) 1.41

Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand (1988) 1.41

Risk factors for neck and upper limb disorders: results from 24 years of follow up. Occup Environ Med (1999) 1.40

Chemical properties of human Ia antigens. Nature (1977) 1.40

[Afraid of labor, afraid of pain--individual management is needed. "Planned delivery" is an alternative to section]. Lakartidningen (1999) 1.39

Normal serum activities of liver enzymes in Swedish paint industry workers with heavy exposure to organic solvents. Br J Ind Med (1985) 1.39

Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther (1993) 1.38

Treatment with tumour necrosis factor alpha antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies. Ann Rheum Dis (2004) 1.38

Cognitive functions in depressive disorders: evidence from a population-based study. Psychol Med (2004) 1.38

Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synovium. Arthritis Rheum (2004) 1.34

Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002). Ann Rheum Dis (2002) 1.33

Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial. Ann Rheum Dis (2005) 1.32